GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Vinmantoo continues to mislead posters on the Yahoo board by implying that GTC’s minority shareholders have the same kind of protection from a lowball buyout by LFB that Genentech’s shareholders had from a lowball buyout by Roche. This is patently false, of course.

DNA’s minority shareholders were protected by a formal contract between Roche and DNA that spelled out the exact conditions under which Roche could buy out the minority shareholders. GTC’s minority shareholders have no such contractual protection.